Smith Jason Drew bought URGN
January 31, 2026 · Form 4 insider transaction
Smith Jason Drew bought 32,609 shares of UroGen Pharma Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 11 days after the transaction.
Direction
Acquired (buy-side)
Shares
32,609
Price
$0.00
Total value
N/A
InsiderSmith Jason Drew
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJanuary 31, 2026
Filing dateFebruary 11, 2026
Shares owned after32,609
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.; 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029.